School of Medicine, University of Virginia, Charlottesville, VA, USA.
Department of Surgery, University of Virginia Health System, Charlottesville, VA, USA.
Oncoimmunology. 2023 Jan 7;12(1):2164476. doi: 10.1080/2162402X.2022.2164476. eCollection 2023.
Tertiary lymphoid structures (TLS) are ectopic lymphoid structures that can arise in human cancers and are associated with improved overall survival (OS) and response to immune checkpoint blockade (ICB) in several cancers, including non-desmoplastic metastatic melanoma (NDMM). Desmoplastic melanoma (DM) has one of the highest response rates to ICB, and we previously identified that primary DM (PDM) contains TLS. Despite the association of TLS with survival and ICB response, it is unknown whether TLS or associated markers of immune activity can differ between PDM and NDMM. We hypothesized that PDM would contain higher frequencies of TLS than NDMM, that T and B-cell densities and proliferation would be greater in TLS of PDM than TLS of NDMM, and that proliferation rates of T and B-cells in PDM TLS would be concordant with those of intratumoral lymphocytes. We found that four features of TLS in PDM distinguish them from TLS in NDMM. TLS were peritumoral in NDMM but intratumoral in PDM. CD8 T-cell and CD20 B-cell densities and proliferative fractions were higher in PDM TLS than NDMM TLS. Additionally, the proliferative fractions of T- and B-cells were concordant between the TLS and tumor site in PDM and discordant in NDMM. Collectively, these data suggest that TLS and associated immune markers can differ across melanoma subsets and suggest that PDM TLS may be more immunologically active and have enhanced immune cell trafficking between tumor and TLS compared to NDMM.
三级淋巴结构 (TLS) 是异位淋巴结构,可在人类癌症中出现,并与几种癌症(包括非促结缔组织增生性转移性黑色素瘤 [NDMM])的总体生存 (OS) 和对免疫检查点阻断 (ICB) 的反应改善相关。促结缔组织增生性黑色素瘤 (DM) 对 ICB 的反应率最高之一,我们之前发现原发性 DM (PDM) 含有 TLS。尽管 TLS 与生存和 ICB 反应相关,但尚不清楚 TLS 或相关免疫活性标志物是否在 PDM 和 NDMM 之间存在差异。我们假设 PDM 中 TLS 的频率高于 NDMM,PDM 中 TLS 的 T 细胞和 B 细胞密度和增殖率高于 NDMM 中 TLS 的,并且 PDM TLS 中 T 和 B 细胞的增殖率与肿瘤内淋巴细胞的增殖率一致。我们发现 PDM 中 TLS 的四个特征可将其与 NDMM 中的 TLS 区分开来。NDMM 中的 TLS 位于肿瘤周围,而 PDM 中的 TLS 位于肿瘤内。PDM TLS 中的 CD8 T 细胞和 CD20 B 细胞密度和增殖分数高于 NDMM TLS。此外,PDM 中 TLS 和肿瘤部位的 T 细胞和 B 细胞增殖分数是一致的,而在 NDMM 中则不一致。总的来说,这些数据表明 TLS 和相关免疫标志物在黑色素瘤亚群之间可能存在差异,并表明与 NDMM 相比,PDM TLS 可能具有更高的免疫活性,并且在肿瘤和 TLS 之间增强了免疫细胞的迁移。